<?xml version="1.0" encoding="UTF-8"?>
<abstract id="16195288">
  <title>
    <s id="0" section="title">
      Cluster randomised trial of
      <group id="0">intermittent  preventive  treatment</group>
      for
      <outcome id="0">malaria</outcome>
      in infants in area of high , seasonal transmission in Ghana .
    </s>
  </title>
  <annotated>
    <s id="2" section="design">
      Cluster randomised placebo controlled trial , with 96 clusters allocated randomly to
      <group id="0">sulfadoxine  -pyrimethamine</group>
      or
      <group id="1">placebo</group>
      in blocks of 8 .
    </s>
    <s id="3" section="interventions">
      Children received
      <group id="0">sulfadoxine  -pyrimethamine</group>
      or
      <group id="1">placebo</group>
      and 1 month of iron supplementation when they received DPT-2 , DPT-3 , or measles vaccinations and at 12 months of age .
    </s>
    <s id="5" section="results">
      89 % ( 1103 /
      <gs group="1">1242</gs>
      ) of children in the
      <group id="1">placebo  group</group>
      and 88 % ( 1088 /
      <gs group="0">1243</gs>
      ) in the
      <group id="0">IPTi  group</group>
      completed follow - up to
      <time id="0">24  months</time>
      of age .
    </s>
    <s id="6" section="results">
      The protective efficacy of
      <group id="0">IPTi</group>
      against
      <outcome id="0">
        all  episodes  of
        <short>malaria</short>
      </outcome>
      was 24.8 % ( 95 % confidence interval 14.3 % to 34.0 % ) up to
      <time id="2">15  months</time>
      of age .
    </s>
    <s id="7" section="results">
      <group id="0">IPTi</group>
      had no protective effect against
      <outcome id="0">malaria</outcome>
      between
      <time id="1">16</time>
      and
      <time id="0">24  months</time>
      of age ( protective efficacy - 4.9 % , - 21.3 % to 9.3 % ) .
    </s>
    <s id="8" section="results">
      The
      <outcome id="0">
        incidence  of  high  parasite  density
        <short>malaria</short>
      </outcome>
      ( &gt; or = 5000 parasites / mul) was higher in the
      <group id="0">IPTi  group</group>
      than in the
      <group id="1">placebo  group</group>
      between
      <time id="1">16</time>
      and
      <time id="0">24  months</time>
      of age ( protective efficacy - 19.5 % , - 39.8 % to - 2.2 % ) .
    </s>
    <s id="9" section="results">
      <group id="0">IPTi</group>
      reduced
      <outcome id="1">
        hospital  admissions  with
        <short>anaemia</short>
      </outcome>
      by 35.1 % ( 10.5 % to 52.9 % ) up to
      <time id="2">15  months</time>
      of age .
    </s>
    <s id="10" section="results">
      <group id="0">IPTi</group>
      had no significant effect on
      <outcome id="1">anaemia</outcome>
      between
      <time id="1">16</time>
      and
      <time id="0">24  months</time>
      of age ( protective efficacy - 6.4 % , - 76.8 % to 35.9 % ) .
    </s>
    <s id="11" section="results">
      The
      <outcome id="2">relative  risk  of  death</outcome>
      up to
      <time id="2">15  months</time>
      of age in the
      <group id="0">IPTi  group</group>
      was 1.26 ( 95 % confidence interval 0.81 to 1.96 ; P = 0.31 ) , and from
      <time id="1">16</time>
      to
      <time id="0">24  months</time>
      it was 1.28 ( 0.77 to 2.14 ; P = 0.35 ) .
    </s>
  </annotated>
  <fulltext>Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high , seasonal transmission in Ghana . To evaluate the effects of intermittent preventive treatment for malaria in infants ( IPTi ) with sulfadoxine -pyrimethamine in an area of intense , seasonal transmission . Cluster randomised placebo controlled trial , with 96 clusters allocated randomly to sulfadoxine -pyrimethamine or placebo in blocks of 8 . Children received sulfadoxine -pyrimethamine or placebo and 1 month of iron supplementation when they received DPT-2 , DPT-3 , or measles vaccinations and at 12 months of age . Incidence of malaria and of anaemia determined through passive case detection . 89 % ( 1103 / 1242 ) of children in the placebo group and 88 % ( 1088 / 1243 ) in the IPTi group completed follow - up to 24 months of age . The protective efficacy of IPTi against all episodes of malaria was 24.8 % ( 95 % confidence interval 14.3 % to 34.0 % ) up to 15 months of age . IPTi had no protective effect against malaria between 16 and 24 months of age ( protective efficacy - 4.9 % , - 21.3 % to 9.3 % ) . The incidence of high parasite density malaria ( &gt; or = 5000 parasites / mul) was higher in the IPTi group than in the placebo group between 16 and 24 months of age ( protective efficacy - 19.5 % , - 39.8 % to - 2.2 % ) . IPTi reduced hospital admissions with anaemia by 35.1 % ( 10.5 % to 52.9 % ) up to 15 months of age . IPTi had no significant effect on anaemia between 16 and 24 months of age ( protective efficacy - 6.4 % , - 76.8 % to 35.9 % ) . The relative risk of death up to 15 months of age in the IPTi group was 1.26 ( 95 % confidence interval 0.81 to 1.96 ; P = 0.31 ) , and from 16 to 24 months it was 1.28 ( 0.77 to 2.14 ; P = 0.35 ) . Intermittent preventive treatment for malaria with sulfadoxine -pyrimethamine can reduce malaria and anaemia in infants even in seasonal , high transmission areas , but concern exists about possible rebound in the incidence of malaria in the second year of life .</fulltext>
  <ignored>
    <s id="1" section="objective">
      To evaluate the effects of
      <group id="0">
        intermittent  preventive  treatment  for  malaria  in  infants  (  IPTi  )  with
        <short>sulfadoxine  -pyrimethamine</short>
      </group>
      in an area of intense , seasonal transmission .
    </s>
    <s id="4" section="main_outcome_measures">
      <outcome id="0">
        Incidence  of
        <short>malaria</short>
      </outcome>
      and of
      <outcome id="1">anaemia</outcome>
      determined through passive case detection .
    </s>
    <s id="12" section="conclusions">
      <group id="0">
        Intermittent  preventive  treatment  for  malaria  with
        <short>sulfadoxine  -pyrimethamine</short>
      </group>
      can reduce
      <outcome id="0">malaria</outcome>
      and
      <outcome id="1">anaemia</outcome>
      in infants even in seasonal , high transmission areas , but concern exists about possible rebound in the
      <outcome id="0">
        incidence  of
        <short>malaria</short>
      </outcome>
      in the second year of life .
    </s>
  </ignored>
</abstract>

